Showing 1 - 20 results of 87 for search '"CAPRISA"', query time: 0.08s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity by Thando Glory Maseko, Santhuri Rambaran, Slindile Ngubane, Lara Lewis, Sinaye Ngcapu, Razia Hassan-Moosa, Derseree Archary, Rubeshan Perumal, Nesri Padayatchi, Kogieleum Naidoo, Aida Sivro

    Published 2023-07-01
    “…Here, we utilized peripheral blood specimens from the Improving Retreatment Success CAPRISA 011 study to characterize NK cell phenotypes during active TB in individuals with or without HIV co-infection. …”
    Get full text
    Article
  5. 5
  6. 6

    Higher plasma interleukin − 6 levels are associated with lung cavitation in drug-resistant tuberculosis by Thando Glory Maseko, Slindile Ngubane, Marothi Letsoalo, Santhuri Rambaran, Derseree Archary, Natasha Samsunder, Rubeshan Perumal, Surie Chinappa, Nesri Padayatchi, Kogieleum Naidoo, Aida Sivro

    Published 2023-08-01
    “…Methods Plasma samples were obtained from 128 participants from the CAPRISA 020 Individualized M(X)drug-resistant TB Treatment Strategy Study (InDEX) prior to treatment initiation. …”
    Get full text
    Article
  7. 7
  8. 8

    Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection by Santhuri Rambaran, Thando Glory Maseko, Lara Lewis, Razia Hassan-Moosa, Derseree Archary, Sinaye Ngcapu, Nigel Garrett, Lyle R. McKinnon, Nesri Padayatchi, Kogieleum Naidoo, Aida Sivro

    Published 2023-07-01
    “…Using flow cytometry, we characterized the frequencies and phenotypic differences in monocytes and dendritic cell populations using peripheral blood mononuclear cells from individuals with recurrent, active pulmonary tuberculosis with and without coexisting HIV infection (CAPRISA 011, Clinicaltrials.gov, NCT02114684, 29/01/2014) and compared them to samples from HIV positive individuals and healthy controls. …”
    Get full text
    Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis by Nandlal L, Perumal R, Naidoo K

    Published 2022-08-01
    “…Louansha Nandlal,* Rubeshan Perumal,* Kogieleum Naidoo* Centre for the AIDS Programme of Research in South Africa (CAPRISA), South African Medical Research Council (SAMRC)-CAPRISA-TB-HIV Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal Nelson R Mandela School of Medicine, Durban, South Africa*These authors contributed equally to this workCorrespondence: Rubeshan Perumal, Centre for the AIDS Programme of Research in South Africa (CAPRISA), South African Medical Research Council (SAMRC)-CAPRISA-TB-HIV Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal Nelson R Mandela School of Medicine, Durban, South Africa, Email Rubeshan.Perumal@caprisa.orgAbstract: The recognition that drug-resistant tuberculosis (DR-TB) poses a major threat to global tuberculosis (TB) control efforts has catalysed the development of new and urgently needed TB diagnostics. …”
    Get full text
    Article